Literature DB >> 12771006

Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Thomas J Wang1, Martin G Larson, Daniel Levy, Ramachandran S Vasan, Eric P Leip, Philip A Wolf, Ralph B D'Agostino, Joanne M Murabito, William B Kannel, Emelia J Benjamin.   

Abstract

BACKGROUND: Atrial fibrillation (AF) and congestive heart failure (CHF) frequently occur together, but there is limited information regarding their temporal relations and the combined influence of these conditions on mortality. METHODS AND
RESULTS: We studied participants in the Framingham Study with new-onset AF or CHF. Multivariable Cox proportional hazards models with time-dependent variables were used to evaluate whether mortality after AF or CHF was affected by the occurrence and timing of the other condition. Hazard ratios (HRs) were adjusted for time period and cardiovascular risk factors. During the study period, 1470 participants developed AF, CHF, or both. Among 382 individuals with both conditions, 38% had AF first, 41% had CHF first, and 21% had both diagnosed on the same day. The incidence of CHF among AF subjects was 33 per 1000 person-years, and the incidence of AF among CHF subjects was 54 per 1000 person-years. In AF subjects, the subsequent development of CHF was associated with increased mortality (men: HR 2.7; 95% CI, 1.9 to 3.7; women: HR 3.1; 95% CI, 2.2 to 4.2). Similarly, in CHF subjects, later development of AF was associated with increased mortality (men: HR 1.6; 95% CI, 1.2 to 2.1; women: HR 2.7, 95% CI, 2.0 to 3.6). Preexisting CHF adversely affected survival in individuals with AF, but preexisting AF was not associated with adverse survival in those with CHF.
CONCLUSIONS: Individuals with AF or CHF who subsequently develop the other condition have a poor prognosis. Additional studies addressing the pathogenesis, prevention, and optimal management of the joint occurrence of AF and CHF appear warranted.

Entities:  

Mesh:

Year:  2003        PMID: 12771006     DOI: 10.1161/01.CIR.0000072767.89944.6E

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  497 in total

1.  Full report from the first annual Heart Rhythm Society Research Forum: a vision for our research future, "dream, discover, develop, deliver".

Authors:  Christine M Albert; Peng-Sheng Chen; Mark E Anderson; Michael E Cain; Glenn I Fishman; Sanjiv M Narayan; Jeffrey E Olgin; Peter M Spooner; William G Stevenson; David R Van Wagoner; Douglas L Packer
Journal:  Heart Rhythm       Date:  2011-11-07       Impact factor: 6.343

Review 2.  Implication from randomized trials of rate and rhythm controls on management of patients with persistent atrial fibrillation.

Authors:  Vincent E Hagens; Dirk J Van Veldhuisen; Harry J G M Crijns; Isabelle C van Gelder
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-04       Impact factor: 1.468

3.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

Review 4.  Promise of factor Xa inhibition in atrial fibrillation.

Authors:  Sana M Al-Khatib; John H Alexander; Renato D Lopes; Kenneth W Mahaffey; Manesh R Patel; Christopher B Granger
Journal:  Curr Cardiol Rep       Date:  2012-02       Impact factor: 2.931

5.  A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women.

Authors:  David Conen; Paul M Ridker; Brendan M Everett; Usha B Tedrow; Lynda Rose; Nancy R Cook; Julie E Buring; Christine M Albert
Journal:  Eur Heart J       Date:  2010-05-25       Impact factor: 29.983

6.  KCNA5 gene polymorphism associate with idiopathic atrial fibrillation.

Authors:  Li Tian; Gang Liu; Le Wang; Mingqi Zheng; Yongjun Li
Journal:  Int J Clin Exp Med       Date:  2015-06-15

7.  Atrial fibrillation: a leading cause of heart failure-related hospitalizations; a dual epidemic.

Authors:  Asrar Ahmed; Waqas Ullah; Ishtiaq Hussain; Sohaib Roomi; Yasar Sattar; Faizan Ahmed; Rehan Saeed; Ammar Ashfaq
Journal:  Am J Cardiovasc Dis       Date:  2019-10-15

8.  Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke.

Authors:  Jonathan P Piccini; Bradley G Hammill; Moritz F Sinner; Adrian F Hernandez; Allan J Walkey; Emelia J Benjamin; Lesley H Curtis; Susan R Heckbert
Journal:  Eur Heart J       Date:  2013-11-25       Impact factor: 29.983

9.  Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation.

Authors:  David P Kao; Gordon Davis; Ryan Aleong; Christopher M O'Connor; Mona Fiuzat; Peter E Carson; Inder S Anand; Jonathan F Plehn; Stephen S Gottlieb; Marc A Silver; JoAnn Lindenfeld; Alan B Miller; Michel White; Guinevere A Murphy; Will Sauer; Michael R Bristow
Journal:  Eur J Heart Fail       Date:  2012-12-07       Impact factor: 15.534

10.  A novel application for the detection of an irregular pulse using an iPhone 4S in patients with atrial fibrillation.

Authors:  David D McManus; Jinseok Lee; Oscar Maitas; Nada Esa; Rahul Pidikiti; Alex Carlucci; Josephine Harrington; Eric Mick; Ki H Chon
Journal:  Heart Rhythm       Date:  2012-12-06       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.